Witnessing the stock’s movement on the chart, on February 11, 2021, Leap Therapeutics Inc. (NASDAQ: LPTX) had a quiet start as it plunged -8.03% to $2.75. During the day, the stock rose to $3.07 and sunk to $2.72 before settling in for the price of $2.99 at the close. Taking a more long-term approach, LPTX posted a 52-week range of $1.15-$3.24.
Meanwhile, its Annual Earning per share during the time was -12.40%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 10.00%. This publicly-traded company’s shares outstanding now amounts to $76.32 million, simultaneously with a float of $44.00 million. The organization now has a market capitalization sitting at $155.90 million. At the time of writing, stock’s 50-day Moving Average stood at $2.21, while the 200-day Moving Average is $2.07.
Leap Therapeutics Inc. (LPTX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Leap Therapeutics Inc.’s current insider ownership accounts for 12.04%, in contrast to 54.50% institutional ownership. According to the most recent insider trade that took place on Jun 22, this organization’s 10% Owner bought 1,750,000 shares at the rate of 2.00, making the entire transaction reach 3,500,000 in total value, affecting insider ownership by 8,476,496.
Leap Therapeutics Inc. (LPTX) Earnings and Revenue Records
As on 9/29/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.09 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.13) by $0.04. This company achieved a return on equity of -886.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.1 per share during the current fiscal year.
Leap Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 10.00% and is forecasted to reach -0.42 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -2.49% through the next 5 years, which can be compared against the -12.40% growth it accomplished over the previous five years trading on the market.
Leap Therapeutics Inc. (NASDAQ: LPTX) Trading Performance Indicators
Let’s observe the current performance indicators for Leap Therapeutics Inc. (LPTX). It’s Quick Ratio in the last reported quarter now stands at 8.70. The Stock has managed to achieve an average true range (ATR) of 0.21. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 141.73.
In the same vein, LPTX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.09, a figure that is expected to reach -0.09 in the next quarter, and analysts are predicting that it will be -0.42 at the market close of one year from today.
Technical Analysis of Leap Therapeutics Inc. (LPTX)
Going through the that latest performance of [Leap Therapeutics Inc., LPTX]. Its last 5-days volume of 1.58 million indicated improvement to the volume of 0.9 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 69.46% While, its Average True Range was 0.24.
Raw Stochastic average of Leap Therapeutics Inc. (LPTX) in the period of the previous 100 days is set at 72.93%, which indicates a major rise in contrast to 53.33% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 90.73% that was lower than 91.13% volatility it exhibited in the past 100-days period.